Search
Axsome Therapeutics Inc
AXSMAdd to Watchlist
132.370USD
+2.570+1.98%
Close 11-05 16:00（ET）
6.93BMarket Cap
LossP/E TTM
Today
+1.98%
5 Days
-7.72%
1 Month
-25.25%
6 Months
-40.66%
Year to Date
-27.52%
1 Year
-2.45%
Key Figures
130.460Open
137.560High
61.35KVolume
LossP/E TTM
27.08P/E Dynamic
--Dividend TTM
0.12%Turnover Ratio
129.800Prev. Close
128.990Low
8.14MTurnover
LossP/E Static
65.76P/B
0.00%Div Yield TTM
-28.74%ROA
260.19052wk High
0.04Volume Ratio
-287.22MNet Profit
52.38MShares
-3.7270EPS TTM
0.46Beta
-349.38%ROE
123.00052wk Low
6.60%Amplitude
92.40%Gross Margin
6.93BMarket Cap
-1.48Reward/Risk
2.83%Risk Rate
Recent
Transcripts
Axsome Therapeutics Inc's Score
-0.18vs previous score
Forecast8.64
Financial Health7.48
Technical4.77
Valuation Dimensions9.55
Institutional Confidence7.00
Risk Assessment7.16
Media Coverage
Coverage Level
Very Low
Very High
Negative-
Analyst Rating
Axsome Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Axsome Therapeutics Inc Latest Earnings Call Transcripts
Axsome Therapeutics (AXSM) Q3 2026 Earnings Call: Revenue Rises 52%
Axsome Therapeutics’ Q3 2026 revenue rose 52% to $259.7 million as AUVELITY sales reached $207.6 million, while net loss narrowed and pipeline programs advanced.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.25/-0.59
Revenue / Forecast
259.69M/249.93M
Axsome Therapeutics Inc Profile
SectorPharmaceuticals
Ticker SymbolAXSM
Number of employees683
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Antecip Capital, L.L.C. | 14.27% |
| BlackRock Institutional Trust Company, N.A. | 6.31% |
| Vanguard Portfolio Management, LLC | 4.00% |
| Vanguard Capital Management, LLC | 3.77% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 38.35% |
| Investment Advisor/Hedge Fund | 22.15% |
| Corporation | 14.27% |
| Hedge Fund | 9.36% |
Related Instruments
-0.79%
+1.43%
+1.07%
-0.14%
+0.38%
-0.22%
+0.03%
-0.41%
+0.02%
-0.20%
+0.85%
-1.57%
-1.04%
+0.28%
+5.27%
-0.16%
+0.16%
-0.80%
+1.46%
+3.63%Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of Axsome Therapeutics Inc (AXSM)?
The current price of Axsome Therapeutics Inc (AXSM) is 129.80.
What is the symbol of Axsome Therapeutics Inc?
The ticker symbol of Axsome Therapeutics Inc is AXSM.
What is the 52-week high of Axsome Therapeutics Inc?
The 52-week high of Axsome Therapeutics Inc is 260.19.
What is the 52-week low of Axsome Therapeutics Inc?
The 52-week low of Axsome Therapeutics Inc is 123.00.
What is the market capitalization of Axsome Therapeutics Inc?
The market capitalization of Axsome Therapeutics Inc is 6.80B.
Is Axsome Therapeutics Inc (AXSM) currently rated as Buy, Hold, or Sell?
According to analysts, Axsome Therapeutics Inc (AXSM) has an overall rating of Buy, with a price target of 279.47.
What is the Earnings Per Share (EPS TTM) of Axsome Therapeutics Inc (AXSM)?
The Earnings Per Share (EPS TTM) of Axsome Therapeutics Inc (AXSM) is -3.73.